Introduction
The ongoing opioid epidemic is a public health crisis that has taken the lives of almost half a million people in the USA, as opioid use disorder (OUD) diagnoses and overdose rates have exponentially increased in the past 10 years.1 A wide range of comorbidities is common among persons with OUD. An understudied comorbidity among persons with OUD is cognitive dysfunction, commonly reported as deficits in executive functioning, attention, working memory and episodic memory.2–6 Cognitive dysfunction can dramatically impede drug treatment engagement and retention in care, resulting in poorer adherence to medications.7 8 It can also adversely impact motivation and behavioural skills that influence treatment outcomes.5 9 Treatment outcomes affected by cognitive dysfunction have been demonstrated to limit treatment compliance, including a reduced willingness to start and stay in treatment, low attendance at behavioural intervention sessions and reduced insight in regard to the benefits of treatment.10 This may be partially explained by poor behavioural intervention effects on patients with OUD, as the strategies used in behavioural interventions for OUD treatments may not be ideally tailored to meet the levels/forms of cognitive dysfunction among this population.11 Therefore, cognitive dysfunction and tailored accommodation strategies must be better understood and carefully matched in order to improve OUD treatment outcomes.12
Several behavioural intervention approaches are used among patients with OUD, including cognitive–behavioural therapy (CBT), contingency management (CM), motivational interviewing (MI) and psychoeducation techniques.11 13 14 While efficacious, these approaches also place significant cognitive demands on patients,14–16 which may limit their efficacy unless appropriate accommodation strategies are incorporated.17 In fact, the Substance Abuse and Mental Health Services Administration (SAMHSA) recently published the Treatment Improvement Protocol to provide treatment recommendations and accommodations for substance use disorder (SUD) treatment targeting people with cognitive dysfunction.17 The American Society of Addictive Medicine has also published treatment criteria with specific behavioural therapy accommodations for adult patients with cognitive dysfunction.18 Building on this foundation and relevant work with other patient populations, this review provides context by describing the cognitive features common to patients with OUD and the cognitive demands that interventions exert. However, our primary aim is to identify potential accommodation strategies to optimise treatment outcomes among patients with OUD for treatment providers. Here, we focus on compensatory accommodation strategies, as opposed to cognitive rehabilitation training that may require additional training, for ideal uptake and optimisation in a clinical drug treatment setting.